Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: a retrospective cohort study
Vishal Patel, Marcus J. Yarwood, Bethany Levick, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 8, pp. 1323-1334
Open Access | Times Cited: 6

Showing 6 citing articles:

Real-world effectiveness of molnupiravir, nirmatrelvir-ritonavir, and sotrovimab on preventing hospital admission among higher-risk patients with COVID-19 in Wales: A retrospective cohort study
Andrew Evans, Cathy Qi, Jubril Omololu Adebayo, et al.
Journal of Infection (2023) Vol. 86, Iss. 4, pp. 352-360
Open Access | Times Cited: 43
Uptake and safety of Sotrovimab for prevention of severe COVID-19 in a cohort and self-controlled case series study
Martina Patone, Andrew JHL Snelling, Holly Tibble, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access | Times Cited: 1
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 and BA.5 subvariant predominance: a systematic literature review
Myriam Drysdale, Mehmet Berktaş, Daniel C. Gibbons, et al.
Infection (2024) Vol. 52, Iss. 5, pp. 1839-1861
Open Access | Times Cited: 4
Real-World Experience with the Available Outpatient COVID-19 THErapies in Patients with canceR (CO.THER)
Angioletta Lasagna, Giulia Gambini, Catherine Klersy, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 999-999
Open Access
Impact of treatment of COVID-19 with sotrovimab on post-acute sequelae of COVID-19 (PASC): an analysis of National COVID Cohort Collaborative (N3C) data
Myriam Gharbi, Rose Chang, Tracy Guo, et al.
Infection (2025)
Open Access
Effectiveness of nirmatrelvir-ritonavir for the treatment of patients with mild to moderate COVID-19 and at high risk of hospitalization: Systematic review and meta-analyses of observational studies
Kathiaja Miranda Souza, G. Carrasco, Robin Rojas-Cortés, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0284006-e0284006
Open Access | Times Cited: 12
Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C)
Christopher F. Bell, Priyanka Bobbili, Raj Desai, et al.
Clinical Drug Investigation (2024) Vol. 44, Iss. 3, pp. 183-198
Open Access | Times Cited: 1
Use of Sotrovimab in Pregnancy: Experiences from the COVID-19 International Drug Pregnancy Registry
Diego F. Wyszynski, Lydia Demetriou, Cheryl Renz, et al.
Drug Safety (2024) Vol. 47, Iss. 9, pp. 843-851
Open Access | Times Cited: 1
Page 1

Scroll to top